While most mild symptoms fade over time, some users can experience severe issues like pancreatitis, gallbladder problems, or kidney damage
NovoCare Savings | Coverage | Support
At these higher doses, the full triple-agonist mechanism is engaged
Injectable GHK-Cu carries more risk , particularly for copper accumulation, if you have underlying conditions affecting copper metabolism (like Wilsons disease or chronic liver disease)
Persistent cold intoleranceespecially with symptoms like numbness, fatigue, or skin changesshould be evaluated by a healthcare provider to identify the cause and guide appropriate treatment
Read clinical review Clinical Reviews GHK-Cu + Thymosin Alpha-1 Stack: Complete Protocol A complete clinical protocol for stacking GHK-Cu (copper tripeptide) with Thymosin Alpha-1, covering mechanisms, dosing, timing, evidence quality, and safety considerations reviewed by the HealthRX medical team